# Irofulven in Treating Patients With Metastatic Colorectal Cancer

> **NCT00003441** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 26 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Irofulven (MGI-114)

## Key facts

- **NCT ID:** NCT00003441
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** 2000-11-08
- **Final completion:** 2000-11-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003441, "Irofulven in Treating Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00003441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*